Proton pump inhibitors and the risk of pancreatic cancer
- PMID: 33544263
- DOI: 10.1007/s00535-021-01764-5
Proton pump inhibitors and the risk of pancreatic cancer
Comment in
-
Proton pump inhibitors and the risk of pancreatic cancer.J Gastroenterol. 2021 Mar;56(3):295-296. doi: 10.1007/s00535-021-01761-8. Epub 2021 Feb 2. J Gastroenterol. 2021. PMID: 33527212 No abstract available.
Dataset described in
-
Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden.J Gastroenterol. 2020 Apr;55(4):453-461. doi: 10.1007/s00535-019-01652-z. Epub 2019 Dec 6. J Gastroenterol. 2020. PMID: 31811561 Free PMC article.
References
-
- Corsonello A, Lattanzio F, Bustacchini S, et al. Adverse events of proton pump inhibitors: potential mechanisms. Curr Drug Metab. 2018;19:142–54. - DOI
-
- Brusselaers N, Sadr-Azodi O, Engstrand L. Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden. J Gastroenterol. 2020;55:453–61. - DOI
-
- Lai SW, Sung FC, Lin CL, et al. Use of proton pump inhibitors correlates with increased risk of pancreatic cancer: a case-control study in Taiwan. Kuwait Med J. 2014;46:44–8.
-
- Lee JK, Merchant SA, Schneider JL, et al. Proton pump inhibitor use and risk of gastric, colorectal, liver, and pancreatic cancers in a community-based population. Am J Gastroenterol. 2020;115:706–15. - DOI
-
- Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the american gastroenterological association. Gastroenterology. 2017;152:706–15. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
